It is not a dietary supplement, a medicine or a foodstuff, it holds no EFSA authorisation as a food ingredient, and it is not intended for consumption or for administration to humans or animals
When its production becomes uneven due to sun exposure, pollution, or hormonal changes, it leads to dark spots and uneven tone
Unfortunately treatment of complex chronic diseases such as obesity has often proven recalcitrant to attempts to attain the desired health benefits [69]
Another factor to consider is whether the potential long term benefits, including weight loss or possible disease improvement, would require continued use of GLP-1 agonist in addition to other IBD treatment options, as this can represent an additional financial or emotional burden on patients.
7 Approximately 3.3 million Canadians have type 1 or type 2 diabetes and this number is expected to rise to 4.8 million by 2024